Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0072 | 0.2523 | 1 |
Schistosoma mansoni | hypothetical protein | 0.018 | 0.8469 | 0.838 |
Echinococcus granulosus | hexokinase type 2 | 0.0085 | 0.3217 | 0.2614 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.0816 | 0.0786 |
Treponema pallidum | hexokinase (hxk) | 0.0085 | 0.3217 | 1 |
Brugia malayi | Hexokinase family protein | 0.0085 | 0.3217 | 0.3217 |
Loa Loa (eye worm) | hexokinase type II | 0.0085 | 0.3217 | 0.3217 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0072 | 0.2523 | 0.2499 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0072 | 0.2523 | 0.2499 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0072 | 0.2523 | 0.2499 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma brucei | hexokinase | 0.0085 | 0.3217 | 0.3195 |
Onchocerca volvulus | 0.0085 | 0.3217 | 1 | |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.1474 | 0.1474 |
Leishmania major | trypanothione reductase | 0.0208 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0072 | 0.2523 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0208 | 1 | 1 |
Onchocerca volvulus | 0.0085 | 0.3217 | 1 | |
Trypanosoma cruzi | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Trypanosoma brucei | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.004 | 0.0749 | 0.0719 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0041 | 0.0816 | 0.0786 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 0.2499 |
Entamoeba histolytica | hexokinase 2 | 0.0085 | 0.3217 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0208 | 1 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0072 | 0.2523 | 0.5 |
Echinococcus multilocularis | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0072 | 0.2523 | 0.2499 |
Echinococcus multilocularis | dna polymerase eta | 0.0068 | 0.2306 | 0.1622 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0033 | 0.0033 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0072 | 0.2523 | 1 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 0.1859 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.004 | 0.004 |
Echinococcus granulosus | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.004 | 0.004 |
Echinococcus granulosus | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0072 | 0.2523 | 0.5 |
Echinococcus multilocularis | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Echinococcus granulosus | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Trypanosoma brucei | unspecified product | 0.0041 | 0.0816 | 0.0786 |
Schistosoma mansoni | hypothetical protein | 0.018 | 0.8469 | 0.838 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.1736 | 0.1736 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0072 | 0.2523 | 0.2499 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0041 | 0.0816 | 0.028 |
Echinococcus multilocularis | hexokinase | 0.0085 | 0.3217 | 0.2614 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0041 | 0.0816 | 0.028 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.1474 | 0.1474 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0072 | 0.2523 | 0.5 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0053 | 0.1471 | 0.1471 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0208 | 1 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0072 | 0.2523 | 0.2523 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.0816 | 0.0786 |
Leishmania major | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0072 | 0.2523 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.004 | 0.0749 | 0.0719 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Toxoplasma gondii | hexokinase | 0.0085 | 0.3217 | 0.3195 |
Loa Loa (eye worm) | hexokinase | 0.0085 | 0.3217 | 0.3217 |
Plasmodium vivax | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.0816 | 0.0786 |
Brugia malayi | hexokinase type II | 0.0027 | 0.004 | 0.004 |
Loa Loa (eye worm) | glutathione reductase | 0.0208 | 1 | 1 |
Trypanosoma cruzi | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Echinococcus granulosus | geminin | 0.018 | 0.8469 | 0.8333 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0072 | 0.2523 | 0.1859 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 0.2087 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.1474 | 0.1474 |
Entamoeba histolytica | hexokinase 1 | 0.0085 | 0.3217 | 1 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma brucei | unspecified product | 0.0028 | 0.0115 | 0.0083 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0072 | 0.2523 | 0.1859 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0072 | 0.2523 | 0.2499 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0033 | 0.0033 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0115 | 0.0083 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0208 | 1 | 1 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0072 | 0.2523 | 0.2499 |
Loa Loa (eye worm) | hexokinase | 0.0053 | 0.1481 | 0.1481 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.2306 | 0.2306 |
Plasmodium vivax | glutathione reductase, putative | 0.0208 | 1 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0053 | 0.1471 | 0.1471 |
Plasmodium falciparum | thioredoxin reductase | 0.0072 | 0.2523 | 0.2499 |
Plasmodium falciparum | glutathione reductase | 0.0208 | 1 | 1 |
Leishmania major | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Trypanosoma brucei | hexokinase | 0.0085 | 0.3217 | 0.3195 |
Trypanosoma brucei | trypanothione reductase | 0.0208 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.1474 | 0.1474 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0041 | 0.0816 | 0.0816 |
Plasmodium falciparum | hexokinase | 0.0085 | 0.3217 | 0.3195 |
Leishmania major | DNA polymerase eta, putative | 0.004 | 0.0749 | 0.0719 |
Leishmania major | DNA polymerase eta, putative | 0.0068 | 0.2306 | 0.228 |
Brugia malayi | Thioredoxin reductase | 0.0208 | 1 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Brugia malayi | Hexokinase family protein | 0.0053 | 0.1481 | 0.1481 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Toxoplasma gondii | thioredoxin reductase | 0.0208 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.018 | 0.8469 | 0.8333 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.0552 | 0.0552 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0072 | 0.2523 | 0.1859 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0208 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0068 | 0.2306 | 0.228 |
Echinococcus granulosus | dna polymerase eta | 0.0068 | 0.2306 | 0.1622 |
Loa Loa (eye worm) | hexokinase | 0.0085 | 0.3217 | 0.3217 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0115 | 0.0083 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0072 | 0.2523 | 0.1859 |
Brugia malayi | hexokinase | 0.0085 | 0.3217 | 0.3217 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 0.1859 |
Onchocerca volvulus | 0.0085 | 0.3217 | 1 | |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0041 | 0.0816 | 0.0816 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0072 | 0.2523 | 1 |
Echinococcus multilocularis | hexokinase type 2 | 0.0085 | 0.3217 | 0.2614 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0072 | 0.2523 | 0.2499 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0072 | 0.2523 | 0.5 |
Schistosoma mansoni | hexokinase | 0.0085 | 0.3217 | 0.2821 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0072 | 0.2523 | 0.2499 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0072 | 0.2523 | 0.2499 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0068 | 0.2306 | 0.2306 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0816 | 0.0786 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0208 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0068 | 0.2306 | 0.228 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0208 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0552 | 0.0552 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0115 | 0.0083 |
Trypanosoma brucei | unspecified product | 0.0028 | 0.0115 | 0.0083 |
Plasmodium falciparum | glutathione reductase | 0.0072 | 0.2523 | 0.2499 |
Leishmania major | hexokinase, putative | 0.0085 | 0.3217 | 0.3195 |
Schistosoma mansoni | DNA polymerase eta | 0.0068 | 0.2306 | 0.1857 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 0.0000124 % | Measurement of binding affinity by displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus | ChEMBL. | 7902439 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.